(Q44711835)
Statements
1 reference
Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension (English)
1 reference
A J Palmer
1 reference
L Annemans
1 reference
S Roze
1 reference
M Lamotte
1 reference
R A Rodby
1 reference
E Ritz
1 reference
1 January 2004
1 reference
1 reference
129
1 reference
1-2
1 reference
13-18
1 reference
Identifiers
1 reference
1 reference